Interferon therapy in myelofibrosis - a systematic review and meta-analysis

BACKGROUND: Myelofibrosis is a Philadelphia chromosome-negative myeloproliferative neoplasm characterized by progressive bone marrow failure, increased risk of progression to AML, and constitutional symptoms. For over three decades various formulations of interferon (IFN) have been used for the trea...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Clin Lymphoma Myeloma Leuk
Main Authors: Bewersdorf, Jan Philipp, Giri, Smith, Wang, Rong, Podoltsev, Nikolai, Williams, Robert T., Rampal, Raajit K., Tallman, Martin S., Zeidan, Amer M., Stahl, Maximilian
Formato: Artigo
Idioma:Inglês
Publicado em: 2020
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7541411/
https://ncbi.nlm.nih.gov/pubmed/32669244
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.clml.2020.05.018
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados